Claritev (CTEV) EBIT Margin (2019 - 2026)

Claritev's EBIT Margin history runs 8 years deep, the most recent figure standing at 2.71% for Q1 2026.

• On a quarterly basis, EBIT Margin fell 150.0% year-over-year to 2.71% in Q1 2026; TTM through Mar 2026 was 2.62%, a 9899.0% increase from a year earlier, with the FY2025 full-year figure at 2.98%, up 15233.0% from the prior year.
• EBIT Margin improved to 2.71% in Q1 2026 per CTEV's latest filing, from 3.09% in the prior quarter.
• Across five years, EBIT Margin topped out at 39.13% in Q1 2022 and bottomed at 254.48% in Q4 2022.
• The 5-year median for EBIT Margin is 4.21% (2025), against an average of 40.08%.
• Across the five-year window, EBIT Margin plunged 29123 bps in 2022 and soared 27120 bps in 2023, its largest moves.
• Year by year, EBIT Margin stood at 254.48% in 2022, then surged by 107 bps to 16.72% in 2023, then tumbled by 207 bps to 17.82% in 2024, then jumped by 83 bps to 3.09% in 2025, then jumped by 188 bps to 2.71% in 2026.
• Per Business Quant, the three latest CTEV EBIT Margin figures stand at 2.71% (Q1 2026), 3.09% (Q4 2025), and 4.09% (Q3 2025).